Irish life sciences company Technopath Clinical Diagnostics has launched its diagnostic reagent kit, the i-plaq test.

The i-plaq test is a blood test using a single human-based serum calibrator and two levels of controls enabling a quick detection of enzymatic activity of lipoprotein-associated phospholipase A2 (Lp-PLA2).

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The Lp-PLA2 is a vascular-specific inflammatory marker considered critical in the formation of rupture-prone plaque from a standard blood test.

"The test is both easy to use and reliable while generating high quality patient results at clinically significant ranges."

Higher levels of Lp-PLA2 are indicative of the fact that the atherosclerotic plaque is more likely to rupture, causing blood clot that could result in cardiovascular disease (CVD) events.

The Lp-PLA2 has a risk ratio similar in magnitude to that of systolic blood pressure and non-HDL cholesterol.

See Also:

The i-plaq test’s performance and ease of use is expected to improve the CVD risk assessment for patients.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Technopath Clinical Diagnostics CEO Malcolm Bell said: "We are very excited to announce the commercialisation of the i-plaqtest kit, a test that is both easy to use and reliable while generating high quality patient results at clinically significant ranges.

"This launch represents a significant development opportunity for our company as we target additional products for this large and growing new market segment."